Provet Pharma Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2009.
2009 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Provet Pharma Private Limited

Provet Pharma Private Limited, a active private limited company, was established on 14 October 2009 in Chennai, Tamil Nadu, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24231TN2009PTC073198. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Employing 116 professional, Its leadership includes Muthu Selvan Vengan (Managing Director), Suthanthirakumar Senthil (Director). Past directors included Muthu Selvan Vengan, Tapan Saha, Sukakumar Somasundaram. It holds ₹26.03 Cr open charges and ₹24.53 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 9, 1St Floor, 2Nd Lane, Chakrapani Street Narasingapuram Extn., Maduvankarai, Guin, Dy, Chennai, Tamil Nadu, 600032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TN2009PTC073198

  • Registration Number

    073198

  • Incorporation Date

    14 October 2009

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 16 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 26.03 Cr
  • Satisfied Charges ₹ 24.53 Cr
  • Revenue Growth **** 57.23%
  • Profit Growth **** 127.80%
  • Ebitda **** 80.53%
  • Net Worth 90.43%
  • Total Assets **** 38.75%
Company report

Provet Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Provet Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Provet Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Muthu Selvan Vengan Managing Director 14 Oct 2009 Current
Suthanthirakumar Senthil Director 14 Oct 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2015 Past
Pramod Abcsdd Director 30 Jan 2015 Past
Pramod Abcsdd Director 06 Jul 2017 Past
Pramod Abcsdd Additional Director 28 Sep 2011 Past
Pramod Abcsdd Additional Director 25 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Provet Pharma.

Provet Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.23% increase. The company also saw a substantial improvement in profitability, with a 127.8% increase in profit. The company's net worth Soared by an impressive increase of 90.43%.

Provet Pharma revenue growth over time
Provet Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 57.23%
*******
*******
*******
*******
Revenue from Operations
*******
 56.29%
*******
*******
*******
*******
Total Assets
*******
 38.75%
*******
*******
*******
*******
Profit or Loss
*******
 127.80%
*******
*******
*******
*******
Net Worth
*******
 90.43%
*******
*******
*******
*******
EBITDA
*******
 80.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Provet Pharma?

In 2023, Provet Pharma had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹260,285,890.00

Satisfied Charges

₹245,318,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 26.03 Cr
Latest Charge Details
Date Lender Amount Status
25 Dec 2021 Hdfc Bank Limited ₹26.03 Cr Open
02 Mar 2022 Others ₹2.50 Cr Satisfied
07 Mar 2017 Others ₹16.03 Cr Satisfied
28 Apr 2010 Indian Bank ₹6.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Provet Pharma?

Provet Pharma has a workforce of 116 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Provet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Provet Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Provet Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Provet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 260.29 M registered on 25 Dec 2021 with Charge ID 100521181 was modified on 28 Jul 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Provet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Charges

    The activity A charge registered on 02 Mar 2022 via Charge ID 100560773 with Others was fully satisfied on 25 Apr 2024. was completed.

  • Charges

    A charge with Others amounted to Rs. 25.00 M with Charge ID 100560773 was registered on 02 Mar 2022. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 07 Mar 2017 via Charge ID 100107021 with Others was fully satisfied on 09 Feb 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Provet Pharma Private Limited?

The CIN of Provet Pharma Private Limited is U24231TN2009PTC073198.

Where is Provet Pharma Private Limited headquartered?

Provet Pharma Private Limited is headquartered at 9, 1St Floor, 2Nd Lane, Chakrapani Street Narasingapuram Extn., Maduvankarai, Guin, Dy, Chennai, Tamil Nadu, 600032.

When was Provet Pharma Private Limited incorporated?

Provet Pharma Private Limited was incorporated on 14 October 2009.

Who are the current directors of Provet Pharma Private Limited?

The current directors of Provet Pharma Private Limited are

What is the primary industry of Provet Pharma Private Limited?

The primary industry of Provet Pharma Private Limited is Manufacturing.

Is Provet Pharma Private Limited a listed company?

Provet Pharma Private Limited is unlisted.

What is the capital structure of Provet Pharma Private Limited?

The authorized capital of Provet Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹2.50 M.

What is the compliance status of Provet Pharma Private Limited?

The compliance status of Provet Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available